Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Bakur Mahmoud

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma MultiformeAlmohanad A Alkayyal, Ahmad Bakur Mahmoud
Anticancer Research|August 28, 2025
Identification of Small Molecule Inhibitors Targeting PD-L1 Protein Using Computational Tools and an Experimental AssayShymaa Damfo, Almohanad A Alkayyal, Ahmad Bakur Mahmoud
Frontiers in Immunology|May 21, 2016
Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral ControlMegan M Tu, Ahmad Bakur Mahmoud, Andrew P Makrigiannis
Cancer Immunology Research|September 20, 2017
Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC ReceptorsMegan M Tu, Mir Munir A Rahim, Céline Sayed, et al.
Diagnostics (Basel, Switzerland)|September 27, 2025
Interferon-Gamma Release Assays Versus Tuberculin Skin Test for Active Tuberculosis Diagnosis: A Systematic Review and Diagnostic Meta-AnalysisMuhammad Abubaker Tobaiqi, Musleh Naser Alshamrani, Shyamkumar Sriram, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
Critical role for the Ly49 family of class I MHC receptors in adaptive natural killer cell responsesAndrew Wight, Ahmad Bakur Mahmoud, Michal Scur, et al.
Frontiers in Immunology|September 28, 2020
Phage Display Derived Monoclonal Antibodies: From Bench to BedsideMohamed A Alfaleh, Hashem O Alsaab, Ahmad Bakur Mahmoud, et al.
Frontiers in Immunology|March 27, 2024
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacySalima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology|April 26, 2014
Ly49 receptors: innate and adaptive immune paradigmsMir Munir A Rahim, Megan M Tu, Ahmad Bakur Mahmoud, et al.
Cancer Research|May 8, 2014
Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cellsMegan M Tu, Ahmad Bakur Mahmoud, Andrew Wight, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma MultiformeAlmohanad A Alkayyal, Ahmad Bakur Mahmoud
Anticancer Research|August 28, 2025
Identification of Small Molecule Inhibitors Targeting PD-L1 Protein Using Computational Tools and an Experimental AssayShymaa Damfo, Almohanad A Alkayyal, Ahmad Bakur Mahmoud
Frontiers in Immunology|May 21, 2016
Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral ControlMegan M Tu, Ahmad Bakur Mahmoud, Andrew P Makrigiannis
Cancer Immunology Research|September 20, 2017
Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC ReceptorsMegan M Tu, Mir Munir A Rahim, Céline Sayed, et al.
Diagnostics (Basel, Switzerland)|September 27, 2025
Interferon-Gamma Release Assays Versus Tuberculin Skin Test for Active Tuberculosis Diagnosis: A Systematic Review and Diagnostic Meta-AnalysisMuhammad Abubaker Tobaiqi, Musleh Naser Alshamrani, Shyamkumar Sriram, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2018
Critical role for the Ly49 family of class I MHC receptors in adaptive natural killer cell responsesAndrew Wight, Ahmad Bakur Mahmoud, Michal Scur, et al.
Frontiers in Immunology|September 28, 2020
Phage Display Derived Monoclonal Antibodies: From Bench to BedsideMohamed A Alfaleh, Hashem O Alsaab, Ahmad Bakur Mahmoud, et al.
Frontiers in Immunology|March 27, 2024
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacySalima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology|April 26, 2014
Ly49 receptors: innate and adaptive immune paradigmsMir Munir A Rahim, Megan M Tu, Ahmad Bakur Mahmoud, et al.
Cancer Research|May 8, 2014
Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cellsMegan M Tu, Ahmad Bakur Mahmoud, Andrew Wight, et al.
Pageof 4